Uncategorized

GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its ‘priority asset’

Published

on

Hansoh Pharmaceutical’s pair of much-hyped ADCs continue to justify partner GSK’s decision to make them priority programs.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version